(USVN) US Treasury 7 Year Note - Ratings and Ratios
Treasury, Notes, Government, Bonds, Securities
Description: USVN US Treasury 7 Year Note
The US Treasury 7 Year Note ETF (NASDAQ:USVN) is designed to track the performance of the ICE BofA Current 7-Year U.S. Treasury Index, which is comprised of the most recently issued 7-year U.S. Treasury note. This means the fund invests at least 80% of its net assets in this specific security, providing investors with exposure to the 7-year segment of the U.S. Treasury yield curve.
As an ETF in the Intermediate Government category, USVN offers a relatively low-risk investment option for those seeking to capitalize on the stability of U.S. government debt. The funds investment strategy is straightforward, focusing on a single security, which simplifies the investment process and minimizes tracking error.
Analyzing the funds characteristics, we can infer that its performance is closely tied to changes in interest rates and the overall direction of the U.S. Treasury market. Given the current interest rate environment and the yield curves shape, we can anticipate that the funds value will be sensitive to shifts in monetary policy and economic indicators.
Using historical price data and technical indicators, we observe that the ETFs price has been relatively stable, with a narrow trading range. The current price of $47.61 is near the 20-day and 50-day Simple Moving Averages (SMA20 and SMA50), indicating a lack of strong trend direction. However, the 200-day Simple Moving Average (SMA200) at $47.27 suggests a slightly positive long-term bias.
Combining technical and fundamental analysis, we can forecast that the USVN ETF will likely continue to track the ICE BofA Current 7-Year U.S. Treasury Index closely. Given the current yield curve and interest rate environment, we anticipate a moderate increase in the funds value over the next quarter, driven by the relatively stable demand for 7-year U.S. Treasury notes. A potential target price could be around $48.20, representing a 1.2% increase from the current price. However, this forecast is contingent on the absence of significant changes in monetary policy or unexpected economic shocks.
Additional Sources for USVN ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
USVN ETF Overview
Market Cap in USD | 7m |
Category | Intermediate Government |
TER | 0.15% |
IPO / Inception | 2023-03-27 |
USVN ETF Ratings
Growth Rating | 26.9 |
Fundamental | - |
Dividend Rating | 56.4 |
Rel. Strength | 7.82 |
Analysts | - |
Fair Price Momentum | 47.15 USD |
Fair Price DCF | - |
USVN Dividends
Dividend Yield 12m | 3.64% |
Yield on Cost 5y | 3.82% |
Annual Growth 5y | 16.05% |
Payout Consistency | 100.0% |
Payout Ratio | % |
USVN Growth Ratios
Growth Correlation 3m | 75.9% |
Growth Correlation 12m | 32.8% |
Growth Correlation 5y | 74.3% |
CAGR 5y | 2.58% |
CAGR/Max DD 5y | 0.31 |
Sharpe Ratio 12m | -0.74 |
Alpha | -0.04 |
Beta | -0.078 |
Volatility | 5.24% |
Current Volume | 0.4k |
Average Volume 20d | 0.6k |
Stop Loss | 47 (-3%) |
As of August 03, 2025, the stock is trading at USD 48.45 with a total of 438 shares traded.
Over the past week, the price has changed by +0.95%, over one month by +0.49%, over three months by +1.03% and over the past year by +3.25%.
Neither. Based on ValueRay´s Analyses, US Treasury 7 Year Note is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 26.93 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of USVN is around 47.15 USD . This means that USVN is currently overvalued and has a potential downside of -2.68%.
US Treasury 7 Year Note has no consensus analysts rating.
According to our own proprietary Forecast Model, USVN US Treasury 7 Year Note will be worth about 50.9 in August 2026. The stock is currently trading at 48.45. This means that the stock has a potential upside of +5.1%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 50.9 | 5.1% |